Benzinga | Oct 23, 2020 07:30AM EDT

CureVac Reports Preclinical Data For Its Covid-19 Vaccine Candidate, CVnCoV; Showed 'Strong induction of antibody and T cell responses in animal models' And A 'Favorable safety profile with no evidence of vaccine-enhanced disease'

https://www.curevac.com/en/2020/10/23/curevac-reports-positive-preclinical-data-for-its-covid-19-vaccine-candidate-cvncov/